Immunome Inc. (IMNM)
9.97
0.59 (6.29%)
At close: Jan 15, 2025, 3:41 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 14.02M | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 22.93M | 631.00K | 755.00K | 755.00K | 615.00K | 521.00K |
| Gross Profit | -8.91M | -631.00K | -755.00K | -755.00K | -615.00K | -521.00K |
| Operating Income | -109.53M | -36.90M | -25.20M | -12.26M | -10.35M | -7.74M |
| Interest Income | 2.72M | 5.00K | 10.00K | 1K | 10.00K | 39.00K |
| Pretax Income | -106.81M | -36.90M | -24.71M | -17.84M | -10.44M | -7.84M |
| Net Income | -106.81M | -37.51M | -24.47M | -17.12M | -10.55M | -7.84M |
| Selling & General & Admin | 19.66M | 13.63M | 11.09M | 4.78M | 1.52M | 866.00K |
| Research & Development | 103.16M | 23.27M | 14.11M | 7.49M | 8.82M | 6.88M |
| Other Expenses | n/a | n/a | 503.00K | n/a | n/a | n/a |
| Operating Expenses | 122.82M | 36.90M | 25.20M | 12.26M | 10.35M | 7.74M |
| Interest Expense | n/a | 5.00K | 10.00K | 38.00K | 106.00K | 141.00K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 123.55M | 36.90M | 25.20M | 12.26M | 10.35M | 7.74M |
| Income Tax | n/a | 617.00K | -242.00K | -717.00K | 106.00K | 39.00K |
| Shares Outstanding (Basic) | 19.84M | 12.13M | 11.54M | 10.11M | 5.74M | 1.09M |
| Shares Outstanding (Diluted) | 19.84M | 12.13M | 11.54M | 10.11M | 5.74M | 1.09M |
| EPS (Basic) | -5.38 | -3.09 | -2.12 | -1.69 | -1.84 | -7.18 |
| EPS (Diluted) | -5.38 | -3.09 | -2.12 | -1.69 | -1.84 | -7.18 |
| EBITDA | -28.27M | -36.27M | -23.95M | -17.04M | -9.72M | -7.18M |
| Depreciation & Amortization | 728.00K | 631.00K | 755.00K | 755.00K | 615.00K | 521.00K |